Update - further information for consumers
Therapeutic Goods Administration (TGA)
Australian Government Department of Health
Main menu
- Home
- Safety information
- Report a problem or side effect
- Alerts
- Recalls
- Prescription opioids
- Medicine shortages
- Early warning system
- Black Triangle Scheme
- Safety information & education
- COVID-19
- COVID-19 treatments
- COVID-19 treatments: Provisional determinations
- Labels for COVID-19 treatments
- Therapeutic Goods (Poisons Standard) (COVID-19 Treatment - GlaxoSmithKline) (Sotrovimab) Labelling Exemption 2021
- COVID-19 treatments: Provisional registrations
- COVID-19 treatments: Treatments undergoing evaluation
- COVID-19 treatments: Advertising compliance
- COVID-19 treatments: Information for consumers and health professionals
- COVID-19 treatments: Information for sponsors (industry)
- COVID-19 vaccines
- Consumers
- Health professionals
- Report a problem or side effect
- Accessing unapproved products
- Advertising
- Medicines
- Medical devices
- Breast implant associated-anaplastic large cell lymphoma (BIA-ALCL)
- Breast implant hub
- Changes to labelling and regulation of hard surface disinfectants (commencing 1 April 2019)
- Information for medical practitioners on pending up-classification of surgical mesh devices
- Importing & supplying medical devices
- Advice about medical devices for health professionals
- Biologicals
- Safety information
- Other resources
- Health professional information & education
- Industry
- SME Assist
- Basics of therapeutic goods regulation
- SME Assist workshops and events
- Educational videos
- Overview of applying for market authorisation
- Understanding ingredient requirements
- Overview of medical devices and IVD regulation
- Researcher considerations
- Interactive decision tools
- Useful resources for business and researchers
- Case studies
- SME Assist podcast series: ‘Navigating therapeutic goods regulation’
- SME guidance material
- Regulation basics
- How therapeutic goods are regulated in Australia
- Australian Register of Therapeutic Goods
- Industry educational materials
- Legislation & legislative instruments
- Advertising hub
- Labelling & packaging
- Ingredients in therapeutic goods
- Exporting therapeutic goods
- Importing therapeutic goods
- Clinical trials
- Cosmetics
- International scientific guidelines
- Safety information for industry
- Medicine shortages
- Advertising therapeutic goods
- Prescription medicines
- Over-the-counter medicines
- Complementary medicines
- Sunscreens
- Medical devices & IVDs
- Australian conformity assessment bodies
- Determinations for Australian conformity assessment bodies
- Face masks and COVID-19
- Medical devices regulation basics
- Unique Device Identification system
- IVD medical devices regulation basics
- Standards, guidelines and publications
- Forms for medical device & IVD sponsors
- Medical devices reforms
- Regulatory decisions and notices
- Biologicals
- Blood and blood components
- Other therapeutic goods
- Manufacturing therapeutic goods
- Manufacturing basics
- Manufacturing medicines
- Manufacturing medical devices & IVDs
- Manufacturing biologicals
- Manufacturing blood and blood components
- Manufacturing inspections
- Forms for manufacturers
- Notices for manufacturers
- Notices about GMP clearance
- Guidance on the management of GMP compliance signals
- Scheduling of medicines & poisons
- SME Assist
- About the TGA
- News room